101 related articles for article (PubMed ID: 11890706)
1. IL-6 induces expression of the Fli-1 proto-oncogene via STAT3.
Hodge DR; Li D; Qi SM; Farrar WL
Biochem Biophys Res Commun; 2002 Mar; 292(1):287-91. PubMed ID: 11890706
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype.
Athanasiou M; Clausen PA; Mavrothalassitis GJ; Zhang XK; Watson DK; Blair DG
Cell Growth Differ; 1996 Nov; 7(11):1525-34. PubMed ID: 8930402
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
4. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells.
Athanasiou M; Mavrothalassitis G; Sun-Hoffman L; Blair DG
Leukemia; 2000 Mar; 14(3):439-45. PubMed ID: 10720139
[TBL] [Abstract][Full Text] [Related]
5. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1.
Bastian LS; Kwiatkowski BA; Breininger J; Danner S; Roth G
Blood; 1999 Apr; 93(8):2637-44. PubMed ID: 10194443
[TBL] [Abstract][Full Text] [Related]
7. Ets-dependent regulation of target gene expression during megakaryopoiesis.
Jackers P; Szalai G; Moussa O; Watson DK
J Biol Chem; 2004 Dec; 279(50):52183-90. PubMed ID: 15466856
[TBL] [Abstract][Full Text] [Related]
8. Inducible expression of the megakaryocyte-specific gene glycoprotein IX is mediated through an Ets binding site and involves upstream activation of extracellular signal-regulated kinase.
Eisbacher M; Khachigian LM; Khin TH; Holmes ML; Chong BH
Cell Growth Differ; 2001 Aug; 12(8):435-45. PubMed ID: 11504709
[TBL] [Abstract][Full Text] [Related]
9. The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells.
Kwiatkowski BA; Zielinska-Kwiatkowska AG; Bauer TR; Hickstein DD
Blood Cells Mol Dis; 2000 Feb; 26(1):84-90. PubMed ID: 10772879
[TBL] [Abstract][Full Text] [Related]
10. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.
Sengupta TK; Talbot ES; Scherle PA; Ivashkiv LB
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11107-12. PubMed ID: 9736697
[TBL] [Abstract][Full Text] [Related]
11. Cytokine signal transduction in P19 embryonal carcinoma cells: regulation of Stat3-mediated transactivation occurs independently of p21ras-Erk signaling.
van Puijenbroek AA; van der Saag PT; Coffer PJ
Exp Cell Res; 1999 Sep; 251(2):465-76. PubMed ID: 10471331
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the ets oncogene family member, fli-1.
Klemsz MJ; Maki RA; Papayannopoulou T; Moore J; Hromas R
J Biol Chem; 1993 Mar; 268(8):5769-73. PubMed ID: 8449942
[TBL] [Abstract][Full Text] [Related]
13. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
15. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6.
Kuo ML; Chuang SE; Lin MT; Yang SY
Oncogene; 2001 Feb; 20(6):677-85. PubMed ID: 11314001
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
[TBL] [Abstract][Full Text] [Related]
18. STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.
Horiguchi A; Oya M; Marumo K; Murai M
Kidney Int; 2002 Mar; 61(3):926-38. PubMed ID: 11849447
[TBL] [Abstract][Full Text] [Related]
19. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells.
Watanabe S; Mu W; Kahn A; Jing N; Li JH; Lan HY; Nakagawa T; Ohashi R; Johnson RJ
Am J Nephrol; 2004; 24(4):387-92. PubMed ID: 15256805
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
